Prognostic significance of thrombocytosis in node-negative colon cancer

Journal of International Medical Research

Volumn 33, Issue 2, 2005, Pages 228-235

  Kandemir, E G ^a   Mayadagli, A ^a   Karagoz, B ^a   Bilgi, O ^a   Turken, O ^a   Yaylaci, M ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Node negative colon cancer; Prognostic factors; Thrombocytosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTOSIS; TUMOR LOCALIZATION;

EID: 14944359614     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000503300211     Document Type: Article

References (35)

1. Ratto C, Sofo L, Ippoliti M, Merico M, Doglietto GB, Crucitti F: Prognostic factors in colorectal cancer. Dis Colon Rectum 1999; 41: 1033-1049.
2. Midgley R, Kerr D: Colorectal cancer. Lancet 1999; 353: 391-399.
3. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JHJM, Cornelisse CJ, et al: Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998; 339: 223-228.
4. Riess L: Zur pathologischen anaotmie des blutes. Arch Anat Physiol Wissensch Med 1872; 39: 237-249.
5. Naschitz JE, Yeshurun D, Eldar S, Lev LM: Diagnosis of cancer-associated vascular disorders. Cancer 1996; 77: 1759-1767.
6. Levin J, Conley CL: Thrombocytosis associated with malignant disease. Arch Intern Med 1964; 114: 497-500.
7. Lavie O, Comerci G, Daras V, Bolger BS, Lopes A, Monaghan IM: Thrombocytosis in women with vulvar carcinoma. Gynecol Oncol 1999; 72: 82-86.
8. Gislason T, Nou E: Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: an epidemiological study. Eur J Respir Dis 1985; 66: 141-146.
9. Lopes A, Daras V, Cross PA, Robertson G, Benyon G, Monaghan JM: Thrombocytosis as a prognostic factor in women with cervical cancer. Cancer 1994; 74: 90-92.
10. Taucher S, Salat A, Gnant M, Kwasny W, Mlineritsch B, Menzel RC, et al: Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost 2003; 89: 1098-1106.
11. Costantini V, Zacharski LR, Moritz TE, Edwards RL: The platelet count in carcinoma of the lung and colon. Thromb Haemost 1990; 64: 501-505.
12. Zeimet AG, Marth C, Muller-Holzner E, Daxenbichler G, Dapunt O: Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1994; 170: 549-554.
13. Silvis SE, Turkbas N, Doscherholmen A: Thrombocytosis in patients with lung cancer. JAMA 1970; 211: 1852-1853.
14. O'Keefe SC, Marshall FF, Issa MM, Harmon MP, Petros JA: Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol 2002; 168: 1378-1380.
15. Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, Masutani S, et al: Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 2002; 9: 287-291.
16. Hernandez E, Donohue KA, Anderson LL, Heller PB, Stehman FB: The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2000; 78: 137-142.
17. Monreal M, Fernandez-Llamazares J, Pinol M, Julian JF, Broggi M, Escola D, et al: Platelet count and survival in patients with colorectal cancer - a preliminary study. Thromb Haemost 1998; 79: 916-918.
18. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, et al: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7: 1194-1201.
19. Verheul HM, Hoekman K, Lupu F, Broxterman HJ, van der Valk P, Kakkar AK, et al: Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin Cancer Res 2000; 6: 166-171.
20. Folman CC, Linthorst GE, van Mourik J, van Willigen G, de Jonge E, Levi M, et al: Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis? Thromb Haemost 2000; 83: 923-930.
21. Ferrara N: Vascular endothelial growth factor. Eur J Cancer 1996; 32: 2413-2422.
22. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-1039.
23. Kumar H, Heer K, Lee PW, Duthie GS, MacDonald AW, Greenman J, et al: Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res 1998; 4: 1279-1285.
24. Dirix LY, Vermeulen PB, Hubens G, Benoy I, Martin M, DePooter C, et al: Serum basic fibroblast growth factor and vascular endothelial growth factor and tumor growth kinetics in advanced colorectal cancer. Ann Oncol 1996; 7: 843-848.
25. Mohle R, Green D, Moore MA, Nachman RL, Rafii S: Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A 1997; 94: 663-668.
26. Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, et al: Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 1996; 2: 821-826.
27. Ma L, Elliott SN, Cirino G, Buret A, Ignarro LJ, Wallace JL: Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci U S A 2001; 98: 6470-6475.
28. Pauly JL, Schuller MG, Zelcer AA, Kirss TA, Gore SS, Germain MJ: Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. J Natl Cancer Inst 1977; 58: 1587-1590.
29. Dabrow MB, Francesco MR, McBrearty FX, Caradonna S: The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. Gynecol Oncol 1998; 71: 29-37.
30. Takebayashi Y, Yamada K, Maruyama I, Fujii R, Akiyama S, Aikou T: The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas. Cancer Lett 1995; 92: 1-7.
31. Van Triest B, Pinedo HM, Blaauwgeers JL, van Diest PJ, Schoenmakers PS, Voom DA, et al: Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. Clin Cancer Res 2000; 6: 1063-1072.
32. Takebayashi R, Akiyama S, Akiba S, Yamada K, Miyedara K, Sumizawa T, et al: Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 1996; 88: 1110-1117.
33. Qian X, Tuszynski GP: Expression of thrombospondin-1 in cancer: a role in tumor progression. Proc Soc Exp Biol Med 1996; 212: 199-207.
34. Arnoletti JP, Albo D, Granick MS, Solomon MP, Castiglioni A, Rothman VL, et al: Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer 1995; 76: 998-1005.
35. Karpatkin S, Pearlstein E: Role of platelets in tumor cell metastases. Ann Intern Med 1981; 95: 636-641.